Paper Details
- Home
- Paper Details
Transcriptomic analysis of benznidazole-resistant and susceptible Trypanosoma cruzi populations.
Author: GonçalvesLeilane Oliveira, GuimarãesPaul Anderson Souza, LiarteDaniel Barbosa, LimaDavi Alvarenga, MurtaSilvane Maria Fonseca, Reis-CunhaJoão Luís, RuizJeronimo Conceição
Original Abstract of the Article :
Chagas disease (CD), caused by the parasite Trypanosoma cruzi, is a serious public health concern in Latin America. Nifurtimox and benznidazole (BZ), the only two drugs currently approved for the treatment of CD, have very low efficacies in the chronic phase of the disease and several toxic side eff...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10204194/
データ提供：米国国立医学図書館（NLM）
Unraveling the Mysteries of Benznidazole Resistance in Trypanosoma cruzi
Chagas disease, caused by the parasite Trypanosoma cruzi, affects millions worldwide. Benznidazole is a critical drug in treating this disease, but resistance poses a major challenge. This research delves into the molecular mechanisms underlying benznidazole resistance in T. cruzi, seeking to uncover the metabolic pathways associated with this resistance. The study compared transcriptomic profiles of wild-type and benznidazole-resistant T. cruzi populations, aiming to identify potential targets for the development of new drugs to combat Chagas disease.
Imagine a desert ecosystem where a resilient species, T. cruzi, has evolved to withstand the harsh conditions of benznidazole treatment. This research, like a dedicated explorer, ventures into the molecular landscape of T. cruzi to understand how resistance arises and explore potential solutions for overcoming this challenge.
New Insights into Chagas Disease Treatment
This study provides valuable insights into the molecular mechanisms behind benznidazole resistance in T. cruzi. By identifying metabolic pathways associated with resistance, the researchers offer potential targets for developing new drugs to combat Chagas disease.
The Quest for Effective Chagas Disease Treatment
This research, like a desert caravan seeking a life-sustaining oasis, highlights the ongoing quest for effective treatment strategies against Chagas disease. It emphasizes the importance of understanding the molecular mechanisms underlying resistance to develop innovative solutions for this challenging disease.
Dr.Camel's Conclusion
This research is like a camel navigating a treacherous desert landscape where the parasite T. cruzi has become resistant to benznidazole. The study, like a map guiding the way, provides insights into the mechanisms of resistance, offering hope for developing new drugs and overcoming this challenge.
Date :
- Date Completed 2023-05-24
- Date Revised 2023-05-25
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.